MYC and lymphoma: We therefore performed IHC using antibodies against CD20 (a B-cell marker), cyclin E, and c-Myc to compare the levels of cyclin E and c-Myc in CD20+ B cells of Δ3C virus-infected versus WT virus-infected lymphomas (Fig 2D).